Tonix Pharmaceuticals Holding (TNXP) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Tonix Pharmaceuticals Holding (TNXP) is Neutral.

The composite score behind that read is -0.15, weighing +0.53 of bullish evidence against -0.35 bearish.

Tonix Pharmaceuticals Holding last closed at $7.30, +0.27% on the session.

Against the IVW growth benchmark the position is -0.53% over the forecast window.

The read is built from 15 underlying insights — 2 bullish and 13 bearish.

Agreement across those insights is 87%.

20 graded predictions for TNXP so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Tonix Pharmaceuticals Holding in the 15th percentile on return on equity, where 100 is best.

Tonix Pharmaceuticals Holding is classified under Health Care / Biotechnology, with a market capitalisation of $124.86M.

StockMap tracks Tonix Pharmaceuticals Holding as the 272nd largest of the 381 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 301 Neutral, 63 Moderate Underperform and 17 Moderate Outperform.

On that composite Tonix Pharmaceuticals Holding ranks 291st of 381 in the group, against a group median of -0.08.